Glen Tullman

Background

Glen E. Tullman (born 1959, near Chicago, Illinois) is an American entrepreneur, investor, and healthcare executive ¹². He received his undergraduate degree in economics and psychology from Bucknell University in 1981 and spent a year at Oxford University studying social anthropology ²³.

Tullman began his career at Certified Collateral Corporation (later CCC Information Systems), a provider of computerized systems for the property and casualty insurance sector, where he rose to President and COO over approximately ten years ²³. He then served as CEO of Enterprise Systems, a leading provider of resource management systems for hospitals, which he took public and later sold to McKesson/HBOC ²³.

In 1997, Tullman became CEO of Allscripts, which under his 15-year leadership became the leading provider of electronic prescribing, practice management, and electronic health records for physician practices ²³. He led the company through its IPO and secondary offerings before departing in 2012 ²³.

After leaving Allscripts, Tullman co-founded 7wire Ventures in 2013 with longtime business partner Lee Shapiro, with whom he had worked for more than 30 years across more than 25 companies ⁴⁵. The firm now manages over $500 million in assets under management across multiple funds ⁶.

When Tullman’s son Sam was diagnosed with type 1 diabetes at age eight, the experience galvanized his commitment to healthcare innovation ¹⁷. In 2014, he founded Livongo Health, a digital health company that provides connected devices and platforms for people with chronic conditions ¹⁷. Tullman led Livongo through what was then the largest consumer digital health IPO in history in 2019, followed by a secondary offering and convertible debt offering raising over $550 million ³. In 2020, Livongo merged with Teladoc Health in a transaction valuing Livongo at $18.5 billion — one of the largest digital health exits in history ¹³.

In 2021, Tullman founded Transcarent, a consumer-directed health and care platform for self-insured employers, where he currently serves as CEO ³⁸. Transcarent achieved unicorn status in 2022 and raised a $126 million Series D in 2024 at a $2.2 billion valuation ⁹.

In April 2024, Tullman launched 62 Ventures, a $100 million venture fund that invests in startups outside the strict digital health focus of 7wire, with areas including health and care, education, environmental sustainability, and international markets (US, India, Middle East) ¹⁰¹¹.

Tullman has invested in and/or co-founded more than 20 businesses throughout his career, including SoCore Energy (a commercial solar company sold to Edison International) and Modern Teacher (a classroom technology company, now part of LEAP Innovations) ¹¹². He is a Life Director of the Illinois Chapter of Breakthrough T1D (formerly JDRF) and incoming Chairperson of the American Diabetes Association ³¹². In 2019, he received the Robert F. Kennedy Human Rights Ripple of Hope Award ³. In 2025, he signed the Giving Pledge, committing the majority of his fortune to philanthropy, including a $100 million commitment to accelerate diabetes research ¹³.

He is the author of On Our Terms: Empowering the New Health Consumer ³.

Stated Thesis

Tullman’s stated investment thesis centers on the “Informed Connected Health Consumer” — the idea that technology can empower individuals to make smarter health and care decisions ⁶¹⁴. Through 7wire Ventures, he has publicly described a focus on companies that improve the consumer healthcare experience, lower costs, and improve clinical outcomes ⁶.

Tullman has stated that when deciding whether to back a company, he starts with clarity: “A founder should be able to explain the value in a few words” ¹⁵. He looks for differentiation (“not just a better version of the same approach”) and purpose-driven founders who have a personal connection to the problem they are solving ¹⁵.

Through 62 Ventures, Tullman has expanded his stated focus beyond strict digital health to include education, environmental sustainability, and companies in the US, India, and the Middle East ¹⁰¹¹. He has described India as his “home away from home as a country” ¹⁰.

At 7wire, the stated thesis includes five digital health segments: connected care, data analytics, personalized consumer markets for health decision-making, population health, and consumer engagement ⁶¹⁴.

Inferred Thesis

Tullman’s personal investment behavior closely tracks his stated thesis — healthcare is overwhelmingly his primary domain, though 62 Ventures signals an intentional expansion.

Operator-investor model: Tullman’s distinctive characteristic as an investor is that he simultaneously operates companies (currently CEO of Transcarent) while investing through 7wire and 62 Ventures. This means his portfolio companies benefit from an active operator’s perspective, but it also means he is not a traditional VC allocating full time to portfolio support. His most successful investments (Livongo, Transcarent, NOCD) are companies where he has taken active board or executive roles — Executive Chairman at NOCD, founder of Livongo, founder of Transcarent ³¹⁶¹⁷.

Sector concentration: Based on his known personal and 7wire portfolio investments, healthcare represents the vast majority of his activity — estimated at 85%+ of known investments. His non-healthcare investments (SoCore Energy, Modern Teacher) predate 7wire and are founder-operated ventures rather than VC investments ¹¹².

Stage distribution: Through 7wire, Tullman invests across stages from seed to growth, with initial check sizes of $100K-$5M ¹⁸. Through 62 Ventures, he invests pre-seed through Series C at $1M-$10M ¹⁰. The 7wire $217M Growth & Opportunity Fund (2023) allocates two-thirds to follow-on investments in existing portfolio companies, indicating a strong bias toward doubling down on winners ⁶.

Founder profile patterns: Tullman shows a strong preference for founders with personal connections to the problems they’re solving — he himself founded Livongo because of his son’s diabetes diagnosis ⁷. Portfolio companies like NOCD (founder Stephen Smith is an OCD patient) and FOLX Health (LGBTQIA+ healthcare) reflect this pattern ¹⁶¹⁹.

Geographic focus: Chicago-headquartered through 7wire, but portfolio companies are geographically diverse. The launch of 62 Ventures specifically targets India and the Middle East alongside US companies ¹⁰¹¹.

Co-investor patterns: General Catalyst is a key co-investor through Livongo and Transcarent ⁹. Through 7wire’s Connected Consumer Health Coalition, strategic LPs (Cigna, Memorial Hermann, Rush University Medical Center) frequently co-invest or serve as early customers for portfolio companies ¹⁴.

The “Hatch” model: A distinctive feature is 7wire’s incubation approach — conceiving and building companies from scratch rather than only investing in external founders. Livongo, Transcarent, and Caraway were all “hatched” by 7wire ⁴²⁰. This blurs the line between investor and founder and is uncommon among healthcare VCs.

Notable gap: Despite Tullman’s stated expansion into education and sustainability through 62 Ventures, the fund’s initial investments (BridgeHealthAI, Khyaal, Loop Health) are all healthcare-adjacent ¹⁰. Whether 62 Ventures will meaningfully diversify beyond healthcare remains to be seen.

Portfolio

Investments attributed to Glen Tullman personally or through vehicles he leads (7wire Ventures, 62 Ventures). 7wire firm-level investments are documented in the firm profile.

This table represents Tullman’s personal and directly-led investments. For the full 7wire Ventures portfolio (28+ verified investments), see the [7wire Ventures firm profile]. Tullman has stated he has invested in and/or co-founded more than 20 businesses throughout his career ¹; only those with verified sources are included above.

In Their Own Words

“My motivation isn’t to build another financially successful company. My motivation is to solve problems in healthcare that we haven’t solved yet.” — Glen Tullman, 4sight Health interview ²³

“The best disruptive idea so far has been the idea behind Livongo. We believed that we could improve the customer experience, improve clinical outcomes and lower the cost of care.” — Glen Tullman, 4sight Health interview ²³

“I make them every day. If you’re trying to innovate every day, you’re trying a lot of new things, and most of them aren’t working.” — Glen Tullman, on mistakes, 4sight Health interview ²³

“My youngest son was diagnosed with Type 1 diabetes when he was 8 years old. When he was diagnosed, I made a commitment to him to help find a cure and keep people healthy until we did.” — Glen Tullman, mHUB Fireside Chat ⁷

“Move quickly, try a lot of things, and keep learning is the answer.” — Glen Tullman, mHUB Fireside Chat ⁷

“Check your ego at the door and just say, let’s get to the answer. It doesn’t matter whose idea it is.” — Glen Tullman, mHUB Fireside Chat ⁷

“Technology perfectly applied is indistinguishable from magic.” — Glen Tullman, mHUB Fireside Chat ⁷

“Every day the world turns upside down on someone who thought they were sitting on top of it.” — Glen Tullman, on a quote he keeps on his desk, StartUp Health Fireside Chat ¹⁵

“Consumers are in charge.” — Glen Tullman, MedCity News, April 2023 ²⁴

“AI is coming and coming quickly to healthcare.” — Glen Tullman, HFMA conference ²⁵

“Think bigger, think differently and maybe take some risk. Because without that, we’re not going to be able to move forward.” — Glen Tullman, HFMA conference ²⁵

“Philanthropy should be proactive, entrepreneurial, performance-driven, and deeply personal. It should be about solving big problems.” — Glen Tullman, Giving Pledge letter, 2025 ¹³

What Founders Say

“That message was reinforced by our Executive Chairman Glen Tullman, who has been absolutely tremendous to NOCD both as an investor and advisor.” — Stephen Smith, Founder and CEO of NOCD, discussing advice about focusing on sales as an early-stage CEO ¹⁷

No additional independently sourced founder testimonials found beyond firm-produced content. The 7wire Ventures website features interviews with portfolio founders (Stephen Smith of NOCD, Andy Hamilton of When Insurance, Susan Rawlings Molina of GroundGame.Health, Dan Michelson of InCommon) through the firm’s “Top of the Ladder” series, but these are firm-produced rather than independent testimonials ²⁶.

Sources